- Omission of chemotherapy for hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: patterns of treatment and outcomes from the Korean Breast Cancer Society Registry
-
Kangleon-Tan HL, Sim J, You JY, Lee ES, Lee H, Yang SM, Seong MK, Park EH, Nam SJ, Park MH, Lee S, Park WC, Kangleon Jr RG, Dy CB, Bae SY, Jung SP, Korean Breast Cancer Society
- KMID: 2536907
- Ann Surg Treat Res.
- 2022 Dec;103(6):313-322.
- doi: 10.4174/astr.2022.103.6.313
Purpose: Although adjuvant chemotherapy (CTx) is still recommended for high-risk patients with hormone receptorpositive and human epidermal receptor (HER)-2-negative breast cancer, recent studies found that selected patients with low disease... -
- CITED
-
- Close
- SHARE
-
- Close
